title: Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.
authors: Department of Clinical Pharmacy, University Medical Centre, Nijmegen, The Netherlands.
authors: D M
authors: DM
authors: Burger
authors: P W
authors: PW
authors: Hugen
authors: M E
authors: ME
authors: van der Ende
authors: P
authors: P
authors: van Wijngaarden
authors: R E
authors: RE
authors: Aarnoutse
authors: P
authors: P
authors: Reiss
authors: J M
authors: JM
authors: Lange
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics*; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000493:pharmacokinetics*; D008297:Male; D010865:Pilot Projects; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects* / Q000493:pharmacokinetics*; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir; D019438:Ritonavir